Percorrendo por Autor SIGNORETTI, SABINA

Ir para: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ou digite as primeiras letras:  
Mostrando regs. 1 a 11 de 11
Data de publicaçãoTítuloAutor(es)
2015Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma.CALLEA, MARCELLA; ALBIGES, LAURENCE; Mampta Gupta, et al
2017Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic ModelDE VELASCO, GUILLERMO; CULHANE, AEDÍN C.; André Poisl Fay, et al
2019Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaNASSAR, AMIN H; HAMIEH, LANA; GRAY, KATHRYN P., et al
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, et al
2016Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell CarcinomaDE VELASCO, GUILLERMO; GRAY, KATHRYN P.; HAMIEH, LANA, et al
2016Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell CarcinomaMAHONEY, KATHLEEN M.; JACOBUS, SUSANNA; BHATT, RUPAL S., et al
2015Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA, et al
2015Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker studyAndré Poisl Fay; SIGNORETTI, SABINA; CALLEA, MARCELLA, et al
2018The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaMCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al
2018The Clinical Activity of PD-1/PD-L1 inhibitors in Metastatic Non-Clear Cell Renal Cell CarcinomaMCKAY, RANA R.; BOSSÉ, DOMINICK; XIE, WANLING, et al
2016Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndré Poisl Fay; DEVELASCO, GUILLERMO; Thai Ho, et al